Blocking the janus-activated kinase pathway reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity by caspase-1 inhibition

Documenti analoghi

• Blocking of Interferon Regulatory Factor 1 Reduces Tumor Necrosis Factor α–Induced Interleukin-18 Bioactivity in Rheumatoid Arthritis Synovial Fibroblasts by Induction of Interleukin-18 Binding Protein a: Role of the Nuclear Interferon Regulatory Factor 1–NF-κB–c-Jun Complex
  di: Marotte, Hubert, et al.
  Pubblicazione: (2011)
• Blocking ERK1/2 reduces TNF-α-induced-IL-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of IL-18BPa Role of ERK1/2 in IL-18 bioactivity regulation
  di: Marotte, Hubert, et al.
  Pubblicazione: (2010)
• Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response
  di: Marotte, Hubert, et al.
  Pubblicazione: (2005)
• Interleukin-18 as an in vivo mediator of monocyte recruitment in rodent models of rheumatoid arthritis
  di: Ruth, Jeffrey H, et al.
  Pubblicazione: (2010)
• Production of tumor necrosis factor alpha, interleukin-1 alpha, and interleukin-6 during murine coccidioidomycosis.
  di: Cox, R A, et al.
  Pubblicazione: (1995)